A cohort of 253 isolated LR resections from 3211 primary STS resections enabled evaluation of post-recurrence prognosticators with median 5.3-year follow-up and 83 disease-specific deaths. Higher LR ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new nanovaccine—a type of vaccine that uses tiny particles for a more ...
Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite advances in oncology, effective treatments for chordoma remain limited.
Professor Shawn Chen Xiaoyuan, Nasrat Muzayyin Professor in Medicine and Technology from the Department of Diagnostic Radiology, and Director at the Nanomedicine Translational Research Programme at ...
Translational Implications of Microbiome Testing Methodologies in Lung Cancer: A Systematic Review of 16S rRNA Sequencing, Shotgun Metagenomics, and Short-Chain Fatty Acid Profiling Although curative ...
A new nanovaccine—a type of vaccine that uses tiny particles for a more targeted delivery to the immune system—could offer a “dual blow” against cancer. This is the finding of researchers from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results